Logo image of HSON

HUDSON GLOBAL INC (HSON) Stock Fundamental Analysis

NASDAQ:HSON - Nasdaq - US4437872058 - Common Stock - Currency: USD

11.15  -0.25 (-2.19%)

Fundamental Rating

3

Overall HSON gets a fundamental rating of 3 out of 10. We evaluated HSON against 82 industry peers in the Professional Services industry. HSON has a great financial health rating, but its profitability evaluates not so good. HSON is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

HSON had negative earnings in the past year.
In the past year HSON has reported a negative cash flow from operations.
In multiple years HSON reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: HSON reported negative operating cash flow in multiple years.
HSON Yearly Net Income VS EBIT VS OCF VS FCFHSON Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5M -5M -10M -15M -20M

1.2 Ratios

Looking at the Return On Assets, with a value of -6.04%, HSON is doing worse than 78.48% of the companies in the same industry.
Looking at the Return On Equity, with a value of -8.04%, HSON is doing worse than 75.95% of the companies in the same industry.
Industry RankSector Rank
ROA -6.04%
ROE -8.04%
ROIC N/A
ROA(3y)6.43%
ROA(5y)2.9%
ROE(3y)9.39%
ROE(5y)4.38%
ROIC(3y)N/A
ROIC(5y)N/A
HSON Yearly ROA, ROE, ROICHSON Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 -20

1.3 Margins

In the last couple of years the Profit Margin of HSON has declined.
HSON has a Gross Margin (49.21%) which is in line with its industry peers.
HSON's Gross Margin has declined in the last couple of years.
HSON does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 49.21%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5Y-35.07%
GM growth 3Y8.86%
GM growth 5Y-4.59%
HSON Yearly Profit, Operating, Gross MarginsHSON Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 40 60

More info and screens

7

2. Health

2.1 Basic Checks

HSON does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for HSON has been increased compared to 1 year ago.
Compared to 5 years ago, HSON has less shares outstanding
HSON has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
HSON Yearly Shares OutstandingHSON Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M
HSON Yearly Total Debt VS Total AssetsHSON Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

2.2 Solvency

Based on the Altman-Z score of -6.44, we must say that HSON is in the distress zone and has some risk of bankruptcy.
HSON has a worse Altman-Z score (-6.44) than 94.94% of its industry peers.
HSON has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -6.44
ROIC/WACCN/A
WACC9.03%
HSON Yearly LT Debt VS Equity VS FCFHSON Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M 60M

2.3 Liquidity

A Current Ratio of 3.27 indicates that HSON has no problem at all paying its short term obligations.
HSON's Current ratio of 3.27 is amongst the best of the industry. HSON outperforms 91.14% of its industry peers.
HSON has a Quick Ratio of 3.27. This indicates that HSON is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 3.27, HSON belongs to the best of the industry, outperforming 91.14% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.27
Quick Ratio 3.27
HSON Yearly Current Assets VS Current LiabilitesHSON Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

More info and screens

4

3. Growth

3.1 Past

The earnings per share for HSON have decreased strongly by -339.58% in the last year.
Measured over the past years, HSON shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -21.78% on average per year.
Looking at the last year, HSON shows a very negative growth in Revenue. The Revenue has decreased by -17.88% in the last year.
HSON shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 19.25% yearly.
EPS 1Y (TTM)-339.58%
EPS 3YN/A
EPS 5Y-21.78%
EPS Q2Q%-264.71%
Revenue 1Y (TTM)-17.88%
Revenue growth 3Y16.74%
Revenue growth 5Y19.25%
Sales Q2Q%-6.46%

3.2 Future

Based on estimates for the next years, HSON will show a very strong growth in Earnings Per Share. The EPS will grow by 33.79% on average per year.
HSON is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.16% yearly.
EPS Next Y-329.13%
EPS Next 2Y-3.5%
EPS Next 3Y33.79%
EPS Next 5YN/A
Revenue Next Year-13.15%
Revenue Next 2Y-2.78%
Revenue Next 3Y2.16%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
HSON Yearly Revenue VS EstimatesHSON Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M 400M 500M
HSON Yearly EPS VS EstimatesHSON Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 2 -2 -4

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for HSON. In the last year negative earnings were reported.
HSON is valuated rather expensively with a Price/Forward Earnings ratio of 17.35.
Based on the Price/Forward Earnings ratio, HSON is valued a bit cheaper than 60.76% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of HSON to the average of the S&P500 Index (22.68), we can say HSON is valued slightly cheaper.
Industry RankSector Rank
PE N/A
Fwd PE 17.35
HSON Price Earnings VS Forward Price EarningsHSON Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
HSON Per share dataHSON EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40 50

4.3 Compensation for Growth

HSON's earnings are expected to grow with 33.79% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-3.5%
EPS Next 3Y33.79%

More info and screens

0

5. Dividend

5.1 Amount

HSON does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

HUDSON GLOBAL INC

NASDAQ:HSON (2/21/2025, 8:26:06 PM)

11.15

-0.25 (-2.19%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)11-12 2024-11-12/bmo
Earnings (Next)03-07 2025-03-07/amc
Inst Owners67.52%
Inst Owner Change-99.44%
Ins Owners18.49%
Ins Owner Change2.35%
Market Cap30.44M
Analysts82.86
Price Target22.44 (101.26%)
Short Float %0.46%
Short Ratio1.59
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend1.01
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-181.29%
Min EPS beat(2)-252.5%
Max EPS beat(2)-110.08%
EPS beat(4)1
Avg EPS beat(4)-578.15%
Min EPS beat(4)-1962.75%
Max EPS beat(4)12.75%
EPS beat(8)1
Avg EPS beat(8)-316.86%
EPS beat(12)4
Avg EPS beat(12)-192.33%
EPS beat(16)7
Avg EPS beat(16)-103.83%
Revenue beat(2)0
Avg Revenue beat(2)-10.21%
Min Revenue beat(2)-20.37%
Max Revenue beat(2)-0.04%
Revenue beat(4)0
Avg Revenue beat(4)-9.33%
Min Revenue beat(4)-20.37%
Max Revenue beat(4)-0.04%
Revenue beat(8)0
Avg Revenue beat(8)-10.08%
Revenue beat(12)3
Avg Revenue beat(12)-5.49%
Revenue beat(16)7
Avg Revenue beat(16)-1.66%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-138.46%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-9.55%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 17.35
P/S 0.22
P/FCF N/A
P/OCF N/A
P/B 0.71
P/tB 0.88
EV/EBITDA N/A
EPS(TTM)-1.15
EYN/A
EPS(NY)0.64
Fwd EY5.76%
FCF(TTM)-0.56
FCFYN/A
OCF(TTM)-0.54
OCFYN/A
SpS51.44
BVpS15.73
TBVpS12.6
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.04%
ROE -8.04%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 49.21%
FCFM N/A
ROA(3y)6.43%
ROA(5y)2.9%
ROE(3y)9.39%
ROE(5y)4.38%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)11.16%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5Y-35.07%
GM growth 3Y8.86%
GM growth 5Y-4.59%
F-Score3
Asset Turnover2.46
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 4.27%
Cap/Sales 0.04%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.27
Quick Ratio 3.27
Altman-Z -6.44
F-Score3
WACC9.03%
ROIC/WACCN/A
Cap/Depr(3y)29.88%
Cap/Depr(5y)37.93%
Cap/Sales(3y)0.16%
Cap/Sales(5y)0.12%
Profit Quality(3y)68.52%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-339.58%
EPS 3YN/A
EPS 5Y-21.78%
EPS Q2Q%-264.71%
EPS Next Y-329.13%
EPS Next 2Y-3.5%
EPS Next 3Y33.79%
EPS Next 5YN/A
Revenue 1Y (TTM)-17.88%
Revenue growth 3Y16.74%
Revenue growth 5Y19.25%
Sales Q2Q%-6.46%
Revenue Next Year-13.15%
Revenue Next 2Y-2.78%
Revenue Next 3Y2.16%
Revenue Next 5YN/A
EBIT growth 1Y-250.03%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-90.33%
EBIT Next 3Y44.65%
EBIT Next 5YN/A
FCF growth 1Y-124.69%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-121.74%
OCF growth 3YN/A
OCF growth 5YN/A